Applied DNA Sciences Inc
APDN5.620USD
0.000
종가 11/04, 16:00（ET）시세는 15분 지연됩니다
5.07M시가총액
손실P/E TTM
자세한 내용은 Applied DNA Sciences Inc 회사
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc 정보
종목 코드 APDN
회사 이름Applied DNA Sciences Inc
상장일Aug 24, 2001
CEOMs. Judith Murrah
직원 수46
유형Ordinary Share
회계 연도 종료Aug 24
주소50 Health Sciences Drive
도시STONY BROOK
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호11790
전화16312408800
웹사이트https://adnas.com/
종목 코드 APDN
상장일Aug 24, 2001
CEOMs. Judith Murrah
Applied DNA Sciences Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
주식 보유 통계
마지막 업데이트: Mon, Nov 3
마지막 업데이트: Mon, Nov 3
주주
주주 유형
주주
주주
비율
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
기타
97.98%
주주
주주
비율
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
기타
97.98%
주주 유형
주주
비율
Hedge Fund
0.79%
Individual Investor
0.63%
Investment Advisor/Hedge Fund
0.41%
Investment Advisor
0.19%
Corporation
0.16%
기타
97.82%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
59
89.41K
1.51%
+65.56K
2025Q2
62
34.98K
6.73%
-8.84K
2025Q1
84
45.20K
34.86%
+11.50K
2024Q4
79
25.60M
46.39%
+1.44M
2024Q3
74
1.08M
9.78%
+703.30K
2024Q2
73
1.19M
10.83%
+424.27K
2024Q1
67
243.32K
209.10%
+86.27K
2023Q4
64
96.98K
13.46%
-84.74K
2023Q3
66
149.12K
21.28%
-82.31K
2023Q2
68
142.47K
21.43%
-74.27K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Anson Funds Management LP.
46.51K
3.6%
+41.94K
+918.33%
Jun 30, 2025
Sabby Management, LLC
24.36K
1.89%
+17.39K
+249.63%
Jun 30, 2025
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Financial Services, Inc.
11.13K
0.86%
+8.82K
+381.65%
Jun 30, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
Tower Research Capital LLC
222.00
0.02%
+190.00
+593.75%
Jun 30, 2025
SBI Securities Co., Ltd.
146.00
0.01%
+79.00
+117.91%
Jun 30, 2025
Grossman (Bruce)
111.00
0.01%
+111.00
--
Feb 02, 2024
Sanctuary Advisors, LLC
20.00
0%
+20.00
--
Dec 31, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
날짜
유형
비율
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
